 |
PDBsum entry 4qd6
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
4qd6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Design, Synthesis and structure-Activity relationships of a novel class of sulfonylpyridine inhibitors of interleukin-2 inducible t-Cell kinase (itk).
|
 |
|
Authors
|
 |
G.Trani,
J.J.Barker,
S.M.Bromidge,
F.A.Brookfield,
J.D.Burch,
Y.Chen,
C.Eigenbrot,
A.Heifetz,
M.H.Ismaili,
A.Johnson,
T.M.Krülle,
C.H.Mackinnon,
R.Maghames,
P.A.Mcewan,
C.A.Montalbetti,
D.F.Ortwine,
Y.Pérez-Fuertes,
D.G.Vaidya,
X.Wang,
A.A.Zarrin,
Z.Pei.
|
 |
|
Ref.
|
 |
Bioorg Med Chem Lett, 2014,
24,
5818-5823.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Starting from benzylpyrimidine 2, molecular modeling and X-ray crystallography
were used to design highly potent inhibitors of Interleukin-2 inducible T-cell
kinase (ITK). Sulfonylpyridine 4i showed sub-nanomolar affinity against ITK, was
selective versus Lck and its activity in the Jurkat cell-based assay was greatly
improved over 2.
|
 |
|
|
|
|
 |